ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements

Autor: Mary Porteous, Kevin M. Chan, Allan R. Glanville, Kristin B. Highland, Siddhartha G. Kapnadak, Matthew G. Hartwig, Olivier Distler, Nicole Davis, Tamara Claridge, Maria Molina, Jasleen Kukreja, Sana Quddus, Michael Perch, Konrad Hoetzenecker, Jesper Magnusson, Dennis M. Lyu, Robin Vos, Maria M. Crespo, P Ging, Usman Ahmad, Robyn T. Domsic, Jorge M. Mallea, Kathleen Stratton, A. Cochrane, Geert Verleden, Irina Timofte
Rok vydání: 2021
Předmět:
Zdroj: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 40(11)
ISSN: 1557-3117
Popis: Patients with connective tissues disease (CTD) are often on immunomodulatory agents before lung transplantation (LTx). Till now, there's no consensus on the safety of using these agents perioperative and post-transplant. The International Society for Heart and Lung Transplantation-supported consensus document on LTx in patients with CTD addresses the risk and contraindications of perioperative and post-transplant management of the biologic disease-modifying antirheumatic drugs (bDMARD), kinase inhibitor DMARD, and biologic agents used for LTx candidates with underlying CTD, and the recommendations and management of non-gastrointestinal extrapulmonary manifestations, and esophageal disorders by medical and surgical approaches for CTD transplant recipients.
Databáze: OpenAIRE